Skip to main content

G 135 Pill - clear white capsule/oblong

Pill with imprint G 135 is Clear / White, Capsule/Oblong and has been identified as Topiramate 25 mg. It is supplied by Glenmark Pharmaceuticals Inc.

Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 135

Topiramate

Imprint
G 135
Strength
25 mg
Color
Clear / White (clear transparent cap and white opaque body)
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc.
National Drug Code (NDC)
68462-0219

Get help with Imprint Code FAQs.

Related images for "G 135"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.